AEON Biopharma, Inc. (AEON) vs Ensysce Biosciences, Inc. (ENSC)
- AEON Biopharma, Inc. AEON 0.23 −4.17%
- Ensysce Biosciences, Inc. ENSC 0.52 −13.33%
AEON Biopharma, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Ensysce Biosciences, Inc. are of similar size ($12.1M and $11.6M). AEON Biopharma, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, AEON Biopharma, Inc. leads on 6 and Ensysce Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | AEON | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (281.32%) | 0.00% |
| Net margin | 0.00% | (280.49%) | 0.00% |
| Free cash flow margin | 0.00% | (196.76%) | 0.00% |
| Return on equity | 350.00% | (1,295.01%) | (56.36%) |
| Return on assets | (621.70%) | (295.92%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack